Hydrocortisone Acetate Suppository shortage
Not a nationwide shortage — Padagis US has told the FDA it is discontinuing its hydrocortisone acetate suppositories.
- The FDA lists this under “To be discontinued” as of Nov 22, 2026: a company stopping its own product.
- 16 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.
- Status
- FDA term: “To Be Discontinued”
- Products on the record
- 2
- Category
- First posted
- Jul 23, 2026
- Last updated
- Jul 23, 2026
This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy
The Bottom Line
Padagis is stopping its hydrocortisone acetate suppositories, and this change may be permanent. The same medicine is still listed in 25 mg and 30 mg strengths by other makers that have not reported a shortage.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Is Hydrocortisone Acetate Being Discontinued? Status as of Nov 22, 2026
Not as a whole, as of Nov 22, 2026. Padagis US is stopping its own version only; 16 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.
The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are listed after them, and the Supply-Risk rating counts them too.
Availability of the Affected Products
From the FDA shortage report: 2 products
Is Every Strength Still Made?
A medicine often comes in several strengths, and more than one company may make each. This shows whether at least one company still makes each strength on the record: a company on the shortage report that still has supply, or another company that sells it.
2 of 2 strengths
- 25 mgStill made by a company
- 30 mgStill made by a company
Other Companies Listing the Same Medicine, Not Reporting a Shortage
Companies that list Hydrocortisone Acetate Suppository with the FDA and have not reported a shortage (not counted in the charts above).
- Cosette Pharmaceuticals, Inc.
- Major Pharmaceuticals
- Marlex Pharmaceuticals, Inc.
- Laser Pharmaceuticals, LLC
- Rising Pharma Holdings, Inc.
- APNAR PHARMA LP
- Patrin Pharma Inc.
- A-S Medication Solutions
- AvPAK
- Golden State Medical Supply, Inc.
- Bryant Ranch Prepack
- Salix Pharmaceuticals, Inc
- Westminster Pharmaceuticals, LLC
- Proficient Rx LP
- Nivagen Pharmaceuticals, Inc.
- AARNA USA INC.
Plus 9 other dosage forms of hydrocortisone acetate.
Shortage Timeline
- Jul 23, 2026 Discontinuation notice on file 2 of 2 products affected.
- Jul 23, 2026 First reported to the FDA 2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
Which Hydrocortisone Acetate Products Are Affected, by Company
Only the companies that told the FDA about a supply problem are listed here, so other companies may still have stock (see Where else can I get hydrocortisone acetate?).
Company: Padagis US LLC
-
Hydrocortisone Acetate Suppository, 30 mg
- Strength
- 30 mg
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
-
Hydrocortisone Acetate Suppository, 25 mg
- Strength
- 25 mg
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
Why Is Padagis US Discontinuing Hydrocortisone Acetate?
A note from Dr. Brian Staiger, PharmD · Written Nov 21, 2026
I looked at what the FDA has on file for this one, and it's pretty simple. Padagis US LLC has reported that it is discontinuing the manufacture of its hydrocortisone acetate suppositories. That means the company is choosing to stop making them, rather than running into a temporary problem like a factory hold-up.
This applies to two products from Padagis: the 25 mg suppository (NDC 0574-7090-12) and the 30 mg suppository (NDC 0574-7093-12). The FDA did not list a specific reason code, and the manufacturer's notes only say "discontinuation of the manufacture of the drug," so there is no public explanation for why. No dates were shared, and no strength or package size was identified as continuing. This report covers only Padagis and these two products.
What Should I Do If I Take Hydrocortisone Acetate?
A note from Dr. Brian Staiger, PharmD · Written Nov 21, 2026
Hydrocortisone acetate suppositories are currently on the FDA drug shortage list, but the overall supply risk is rated low (1 of 5). The shortage report comes from one company, Padagis US LLC, which is discontinuing its 25 mg and 30 mg suppositories. Neither strength has a source from Padagis right now. Both the 25 mg and 30 mg strengths are still listed by other companies that did not report a shortage.
The reported reason is that Padagis has stopped making this product. Because it is marked "to be discontinued," supply from Padagis may not return. This affects only that one maker. Several other companies, including Cosette, Major, Marlex, Laser, Rising, APNAR, Patrin and A-S Medication Solutions, list the same medicine in 25 mg and/or 30 mg.
What you can do:
- Do not stop, skip, or change how you use this medicine on your own.
- Ask your pharmacy to order the same medicine from another maker in your strength. They can check wholesalers, though it may not be in local stock right away.
- If your strength cannot be found, talk with your prescriber or pharmacist about options. A clinician should choose any alternative.
- Padagis's contact number is listed on this page for reference. Pharmacies usually handle these calls.
This is general information based on national, manufacturer-reported FDA data. It may not match your local pharmacy's stock, and it is not personal medical advice.
Quick checklist for the pharmacy counter
- Ask your pharmacy to check other companies’ versions, other strengths, package sizes, and nearby stores — the options below are a starting point.
- If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.
Where Else Can I Get Hydrocortisone Acetate?
From the current FDA NDC Directory: the same medicine from companies that have not reported a shortage and other dosage forms.
- Some listings are repackagers, which relabel another company’s product.
- A listing is not stock: these may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same Medicine From Other Companies (Not Reporting a Shortage)
The same active ingredient, dosage form and route, from companies that have not reported a shortage to the FDA.
| Product | Strength | Form / route | Company | NDC |
|---|---|---|---|---|
| Hydrocortisone Acetate | 30 mg | Suppository · Rectal | Cosette Pharmaceuticals, Inc. | 00713-0493-12 |
| Anucort-Hc | 25 mg | Suppository · Rectal | Cosette Pharmaceuticals, Inc. | 00713-0503-01 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | Major Pharmaceuticals | 00904-7340-12 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | Marlex Pharmaceuticals, Inc. | 10135-0751-12 |
| Hemmorex-Hc | 25 mg | Suppository · Rectal | Laser Pharmaceuticals, LLC | 16477-0201-12 |
| Hemmorex-Hc | 30 mg | Suppository · Rectal | Laser Pharmaceuticals, LLC | 16477-0202-12 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | Rising Pharma Holdings, Inc. | 16571-0676-21 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | APNAR PHARMA LP | 24689-0102-01 |
| Hydrocortisone Acetate | 30 mg | Suppository · Rectal | APNAR PHARMA LP | 24689-0103-01 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | Patrin Pharma Inc. | 39328-0029-12 |
| Hydrocortisone Acetate | 30 mg | Suppository · Rectal | Patrin Pharma Inc. | 39328-0129-12 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | A-S Medication Solutions | 50090-6331-00 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | AvPAK | 50268-0411-01 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | Golden State Medical Supply, Inc. | 51407-0665-12 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | Bryant Ranch Prepack | 63629-2530-01 |
| Hydrocortisone Acetate | 30 mg | Suppository · Rectal | Bryant Ranch Prepack | 63629-2531-01 |
| Anusol Hc | 25 mg | Suppository · Rectal | Salix Pharmaceuticals, Inc | 65649-0411-12 |
| Proctocort | 30 mg | Suppository · Rectal | Salix Pharmaceuticals, Inc | 65649-0511-12 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | Westminster Pharmaceuticals, LLC | 69367-0243-12 |
| Hydrocortisone Acetate | 30 mg | Suppository · Rectal | Westminster Pharmaceuticals, LLC | 69367-0260-12 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | Proficient Rx LP | 71205-0976-12 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | Nivagen Pharmaceuticals, Inc. | 75834-0147-12 |
| Hydrocortisone Acetate | 25 mg | Suppository · Rectal | AARNA USA INC. | 82568-0150-01 |
| Hydrocortisone Acetate | 30 mg | Suppository · Rectal | AARNA USA INC. | 82568-0160-01 |
Other Dosage Forms of Hydrocortisone Acetate
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Aerosol, Foam
Cream
- Good Neighbor Pharmacy Hydrocortisone With Aloe For Sensitive Skin — HYDROCORTISONE .5 g/100gAmerisourceBergen · Topical
- Good Neighbor Pharmacy Hydrocortisone With Aloe — HYDROCORTISONE 1 g/100gAmerisourceBergen · Topical
- Hydrocortisone Acetate Cream — HYDROCORTISONE ACETATE 20 mg/gAllegis Pharmaceuticals, Inc. · Topical
- Vanicream Hc Anti-Itch — HYDROCORTISONE ACETATE 1.12 g/100gPharmaceutical Specialties, Inc. · Topical
- Hydrocortisone Acetate Cream — HYDROCORTISONE ACETATE 20 mg/gAllegis Holdings LLC · Topical
Ointment
Therapeutic Equivalents and Pricing 30 products
Other products the FDA rates as interchangeable with the affected strengths, with what pharmacies pay for each and whether pharmacies are still buying it. Cheapest first.
| Product | Manufacturer | Package | Pharmacy cost per unit (NADAC) | FDA rated equivalent | Availability |
|---|---|---|---|---|---|
| Hydrocortisone Acetate 25 mgNDC 24689-0102-01 | APNAR | 12 suppositories | $1.101 | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 00904-7340-12 | Major | 12 suppositories | $1.114 | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 16571-0676-21 | Rising | 12 suppositories | $1.114 | — | FDA listed |
| Hydrocortisone Acetate 30 mgNDC 00574-7093-12 | Padagis | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 30 mgNDC 00713-0493-12 | Cosette | 12 suppositories | — | — | FDA listed |
| Hemmorex-HC 30 mgNDC 16477-0202-12 | Laser | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 30 mgNDC 16571-0164-21 | Rising | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 30 mgNDC 24689-0103-01 | APNAR | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 30 mgNDC 39328-0129-12 | Patrin | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 30 mgNDC 63629-2531-01 | Bryant | 12 suppositories | — | — | FDA listed |
| Proctocort 30 mgNDC 65649-0511-12 | Salix | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 30 mgNDC 69367-0260-12 | Westminster | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 30 mgNDC 82568-0160-01 | AARNA | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 00574-7090-12 | Padagis | 12 suppositories | — | — | FDA listed |
| Anucort-Hc 25 mgNDC 00713-0503-01 | Cosette | 100 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 10135-0751-12 | Marlex | 12 suppositories | — | — | FDA listed |
| Hemmorex-HC 25 mgNDC 16477-0201-12 | Laser | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 39328-0029-12 | Patrin | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 50090-6331-00 | A-S | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 50268-0411-01 | AvPAK | 100 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 51407-0665-12 | Golden | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 63629-2530-01 | Bryant | 12 suppositories | — | — | FDA listed |
| Anusol HC 25 mgNDC 65649-0411-12 | Salix | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 68071-2259-02 | NuCare | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 69367-0243-12 | Westminster | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 70752-0169-02 | QUAGEN | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 71205-0976-12 | Proficient | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 75834-0147-12 | Nivagen | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 82568-0150-01 | AARNA | 12 suppositories | — | — | FDA listed |
| Hydrocortisone Acetate 25 mgNDC 68788-4190-01 | Preferred | 12 suppositories | — | — | FDA listed |
These have the same ingredient, strength, form and route, and the FDA rates them as substitutes (an “AB” rating in its Orange Book). The price is what pharmacies pay on average (CMS’s NADAC survey), not what you pay. Availability comes from recent pharmacy prices, not a stock check.
Codes & Classification for pharmacists and billers
- GCN Seq No
- 031773
- GCN
- 27944
- HICL code
- 002863
- Ingredient (HICL)
- Hydrocortisone Acetate
- HIC1 code
- Q
- Therapeutic class — broad (HIC1)
- Ear/Eye/Nose/Rectum/Topical/Vagina/Other
- HIC2 code
- Q3
- Therapeutic class — intermediate (HIC2)
- Anal-Rectal Preparations
- HIC3 code
- Q3A
- Therapeutic class — specific (HIC3)
- Rectal Preparations
- AHFS code
- 84:06.08.00
- AHFS class
- Corticosteroids (Skin, Mucous Membrane)
- FDB label name
- HYDROCORTISONE AC 30 MG SUPP
- FDB brand name
- Hydrocortisone Acetate
- Legend status
- F — Federal legend — prescription drug or device
- GPI-14
- 89100010105237
- GPI class
- Hydrocortisone Acetate
Where does this data come from? Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.
Hydrocortisone acetate Shortage FAQs
Is hydrocortisone acetate discontinued?
Only Padagis US’s version. Padagis US has told the FDA it is stopping its own product (listed under “To be discontinued” as of Nov 22, 2026), while 16 other companies still sell the same medicine and have not reported a problem (Cosette Pharmaceuticals, Major Pharmaceuticals, Marlex Pharmaceuticals and 13 more). It is not a nationwide shortage.
Which strengths of hydrocortisone acetate are affected?
The FDA record covers 2 strengths: 25 mg, 30 mg. Every strength on the record is still made by at least one company, though stock varies by pharmacy.
Which hydrocortisone acetate products are affected?
Hydrocortisone Acetate Suppository, 30 mg (NDC 00574-7093-12); Hydrocortisone Acetate Suppository, 25 mg (NDC 00574-7090-12). The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.
When will hydrocortisone acetate be available again?
A discontinuation is usually permanent for that company’s product. The same medicine is still sold by Cosette Pharmaceuticals, Major Pharmaceuticals, Marlex Pharmaceuticals and 13 more, so ask your pharmacy to order another company’s version.
Can I still get hydrocortisone acetate somewhere?
Other companies (Cosette Pharmaceuticals, Major Pharmaceuticals, Marlex Pharmaceuticals and 13 more) sell the same medicine and have not reported a problem. 9 other dosage forms of hydrocortisone acetate are also listed. See “Where else can I get hydrocortisone acetate?” above — stock still varies by pharmacy.
What should I do if I take hydrocortisone acetate?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different strength or package size, and ask your prescriber about a long-term plan before your supply runs out.
How to Read the Supply-Risk Rating
Each drug in shortage gets one point for each of five risk factors that apply to it (listed with its rating). It is our estimate across the country, not a check of your pharmacy’s shelves.
- Low0 to 2 risk factors Your pharmacy can often still get it, though it may need to be ordered.Hydrocortisone acetate is rated Low: 0 of 5 risk factors.
- Medium3 risk factors Supply is tight in several ways. Finding it may take some calling around.
- High4 or 5 risk factors, or no company found making it Few companies are left making it, or some strengths have no maker at all. It may be hard to find for a while.
Back to this drug’s rating ↑ · How we rate supply risk, in full
Where This Data Comes From
- The FDA’s drug shortage database, checked every day: the companies, their products and the codes on their boxes (NDCs), the status, the reason and the dates. See the FDA’s record for this shortage ↗
- The FDA’s NDC Directory: the other companies that make the same medicine, which the supply-risk rating counts.
- First Databank and CMS NADAC: matching the same medicine across companies, and what pharmacies pay for the equivalents.
For reference only. Check with your pharmacist, the drug’s maker or the FDA before acting on it.